Dublin, April 21, 2026 (GLOBE NEWSWIRE)-- The "Bispecific Antibody Market Opportunity, Antibody Dosage, Patent, Price, Sales & Clinical Trials Outlook 2031" report has been added to ResearchAndMarkets ...
Delhi, April 04, 2025 (GLOBE NEWSWIRE) -- Over the last two decades, immunotherapy has transformed treatment strategies across various medical fields. The effectiveness of monoclonal antibodies in ...
Invivyd authors evaluated early side effects of prior low-dose investigational monoclonal antibody adintrevimab from the EVADE study, ...
NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio Corporation (Nasdaq: RLYB) today announced preliminary data from the completed multiple dose cohort of the Phase 1 safety and pharmacokinetics (PK) study ...
In part 1 of our interview with Anna Sureda, MD, PhD, president of the European Group for Blood and Marrow Transplantation, she summarized the current treatment landscape for relapsed/refractory ...
The US Food and Drug Administration on Thursday revised the emergency use authorization for Evusheld, a monoclonal antibody against Covid-19 for immunocompromised people and those who cannot be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results